Trends in outpatient antibiotic use and prescribing practice among US older adults, 2011-15: observational study

Abstract Objective To identify temporal trends in outpatient antibiotic use and antibiotic prescribing practice among older adults in a high income country. Design Observational study using United States Medicare administrative claims in 2011-15. Setting Medicare, a US national healthcare program for which 98% of older adults are eligible. Participants 4.5 million fee-for-service Medicare beneficiaries aged 65 years old and older. Main outcome measurements Overall rates of antibiotic prescription claims, rates of potentially appropriate and inappropriate prescribing, rates for each of the most frequently prescribed antibiotics, and rates of antibiotic claims associated with specific diagnoses. Trends in antibiotic use were estimated by multivariable regression adjusting for beneficiaries’ demographic and clinical covariates. Results The number of antibiotic claims fell from 1364.7 to 1309.3 claims per 1000 beneficiaries per year in 2011-14 (adjusted reduction of 2.1% (95% confidence interval 2.0% to 2.2%)), but then rose to 1364.3 claims per 1000 beneficiaries per year in 2015 (adjusted reduction of 0.20% over 2011-15 (0.09% to 0.30%)). Potentially inappropriate antibiotic claims fell from 552.7 to 522.1 per 1000 beneficiaries over 2011-14, an adjusted reduction of 3.9% (3.7% to 4.1%). Individual antibiotics had heterogeneous changes in use. For example, azithromycin claims per beneficiary decreased by 18.5% (18.2% to 18.8%) while levofloxacin claims increased by 27.7% (27.2% to 28.3%). Azithromycin use associated with each of the potentially appropriate and inappropriate respiratory diagnoses decreased, while levofloxacin use associated with each of those diagnoses increased. Conclusion Among US Medicare beneficiaries, overall antibiotic use and potentially inappropriate use in 2011-15 remained steady or fell modestly, but individual drugs had divergent changes in use. Trends in drug use across indications were stronger than trends in use for individual indications, suggesting that guidelines and concerns about antibiotic resistance were not major drivers of change in antibiotic use.

[1]  P. Flowers,et al.  Effectiveness of interventions to improve the public’s antimicrobial resistance awareness and behaviours associated with prudent use of antimicrobials: a systematic review , 2018, The Journal of antimicrobial chemotherapy.

[2]  H. Goossens,et al.  Global increase and geographic convergence in antibiotic consumption between 2000 and 2015 , 2018, Proceedings of the National Academy of Sciences.

[3]  V. Fraser,et al.  Outpatient Antibiotic Prescription Trends in the United States: A National Cohort Study , 2018, Infection Control & Hospital Epidemiology.

[4]  T. Smieszek,et al.  Antibiotics in primary care in England: which antibiotics are prescribed and for which conditions? , 2018, The Journal of antimicrobial chemotherapy.

[5]  T. Smieszek,et al.  Potential for reducing inappropriate antibiotic prescribing in English primary care , 2018, The Journal of antimicrobial chemotherapy.

[6]  T. Smieszek,et al.  Actual versus ‘ideal’ antibiotic prescribing for common conditions in English primary care , 2018, The Journal of antimicrobial chemotherapy.

[7]  T. Smieszek,et al.  Defining the appropriateness and inappropriateness of antibiotic prescribing in primary care , 2018, The Journal of antimicrobial chemotherapy.

[8]  L. Davidson,et al.  Patient, Provider, and Practice Characteristics Associated with Inappropriate Antimicrobial Prescribing in Ambulatory Practices , 2018, Infection Control & Hospital Epidemiology.

[9]  G. Schumock,et al.  Antibiotic Expenditures by Medication, Class, and Healthcare Setting in the United States, 2010–2015 , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  A. Collins,et al.  Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US , 2017, Clinical epidemiology.

[11]  Linnea A. Polgreen,et al.  Phantom Prescribing: Examining the Frequency of Antimicrobial Prescriptions Without a Patient Visit , 2016, Infection Control & Hospital Epidemiology.

[12]  S. Aitken,et al.  Regional variation in antibiotic prescribing among medicare part D enrollees, 2013 , 2016, BMC Infectious Diseases.

[13]  Prevalence of Inappropriate Antibiotic Prescriptions among US Ambulatory Care Visits, 2010-2011 , 2016 .

[14]  J. Guo,et al.  Off‐label use of oral fluoroquinolone antibiotics in outpatient settings in the United States, 2006 to 2012 , 2016, Pharmacoepidemiology and drug safety.

[15]  S. Schrag,et al.  US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Lisa G Winston,et al.  Burden of Clostridium difficile Infection in the United States , 2015 .

[17]  Bryan T Grenfell,et al.  Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. , 2014, The Lancet. Infectious diseases.

[18]  Grace C. Lee,et al.  Outpatient antibiotic prescribing in the United States: 2000 to 2010 , 2014, BMC Medicine.

[19]  Michael Lawrence Barnett,et al.  Antibiotic prescribing for adults with acute bronchitis in the United States, 1996-2010. , 2014, JAMA.

[20]  Daniel J. Shapiro,et al.  Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. , 2014, The Journal of antimicrobial chemotherapy.

[21]  Michael Lawrence Barnett,et al.  Antibiotic prescribing to adults with sore throat in the United States, 1997-2010. , 2014, JAMA internal medicine.

[22]  Yuting Zhang,et al.  Geographic variation in outpatient antibiotic prescribing among older adults. , 2012, Archives of internal medicine.

[23]  C Michael Stein,et al.  Azithromycin and the risk of cardiovascular death. , 2012, The New England journal of medicine.

[24]  Sepheen C. Byron,et al.  Variation in outpatient antibiotic prescribing in the United States. , 2009, The American journal of managed care.

[25]  J. Levy,et al.  Adverse selection in the Medicare prescription drug program. , 2009, Health affairs.

[26]  Carlos G. Grijalva,et al.  Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. , 2009, JAMA.

[27]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Robert S. Dittus,et al.  Trends in antibiotic prescribing for adults in the United States—1995 to 2002 , 2005, Journal of General Internal Medicine.

[29]  J. Hughes,et al.  Antimicrobial-Drug Prescription in Ambulatory Care Settings, United States, 1992–2000 , 2003, Emerging infectious diseases.

[30]  Ralph Gonzales,et al.  Changing Use of Antibiotics in Community-Based Outpatient Practice, 19911999 , 2003, Annals of Internal Medicine.

[31]  M. Pichichero.  Dynamics of antibiotic prescribing for children. , 2002, JAMA.

[32]  F. Martinez,et al.  Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  D. Malone,et al.  Excessive antibiotic use for acute respiratory infections in the United States. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  J. Burke.  Antibiotic resistance--squeezing the balloon? , 1998, JAMA.

[35]  P Huovinen,et al.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. , 1997, The New England journal of medicine.

[36]  J. Hughes,et al.  Trends in antimicrobial drug prescribing among office-based physicians in the United States. , 1995, JAMA.

[37]  H. White,et al.  Some heteroskedasticity-consistent covariance matrix estimators with improved finite sample properties☆ , 1985 .